Navigation Links
These cells will self-destruct in 5 ... 4 ...
Date:9/7/2010

Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough. For instance, taking a drug that targets fast-growing tumor cells frequently results in hair loss, because cells in the hair follicle are among some of the fastest growing in the body. When it comes down to it, these drugs get the diagnosis wrong.

But what if we had cancer treatments that worked more like a computer program, which can perform actions based on conditional statements? Then, a treatment would kill a cell if --and only if-- the cell had been diagnosed with a mutation. Only the defective cells would be destroyed, virtually eliminating unwanted side effects.

With support from the National Science Foundation (NSF), researchers at the California Institute of Technology have created conditional small RNA molecules to perform this task. Their strategy uses characteristics that are built into our DNA and RNA to separate the diagnosis and treatment steps.

"The molecules are able to detect a mutation within a cancer cell, and then change conformation to activate a therapeutic response in the cancer cell, while remaining inactive in cells that lack the cancer mutation," claims Niles Pierce, co-author of a recent study which appears in the September 6 issue of Proceedings of the National Academy of Sciences (PNAS).

This work is part of the Molecular Programming Project, funded by NSF's Directorate for Computer & Information Science & Engineering. One of the goals of the project is to increase understanding of how information can be stored and processed by
'/>"/>

Contact: Lisa Van Pay
lvanpay@nsf.gov
703-292-8796
National Science Foundation
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Material tested that could guarantee body protheses for more than 150 years
2. Duty of Care - New Driving Legislation Could Put You in Court! UKContractHireandLeasing spread the word on these new regulations
3. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
4. New study suggests stem cells sabotage their own DNA to produce new tissues
5. Attacking cancer cells with hydrogel nanoparticles
6. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
7. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
8. New tool illuminates connections between stem cells and cancer
9. Bitter melon extract attacks breast cancer cells
10. Heart Stem Cells Move Closer to Human Treatments
11. Notch-blocking drugs kill brain cancer stem cells, yet multiple therapies may be needed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
These cells will self-destruct in 5 ... 4 ...
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... Those looking to catch a new and refreshing show on Broadway, look no further ... achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel ...
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Transfinder, a software ... , Total sales were up 16 percent year-over-year for the first six months ended ... Civitella said he expected Transfinder to beat last year’s record-revenue mark of $10.4 million. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley Associates , ... the 2015 Aster Awards national competition for a marketing communications campaign created for ... surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze Award was ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2
... new test that screens babies for the presence of a ... on Tuesday. Group B streptococcus// is a common infection that ... pneumonia, meningitis, neurological damage or even death. ,Although ... current screening methods can leave some babies at risk for ...
... the mind are really mysterious, however these have inspired ... of the brain affected by the// personality disorder schizophrenia. ... into a tool that can help diagnose the condition. ... of people with schizophrenia is yet to be pinned ...
... medication have long been the cornerstones of managing type ... benefits// these patients. ,Now, a new systematic ... levels, increases the body’s sensitivity to insulin, and decreases ... fat. ,“Type 2 diabetes is an increasing ...
... by Satish K. Pillai, PhD, a staff research associate at ... San Francisco it was found that HIV in the brain ... ,The patients suffered severe to moderate cognitive decline. ... a particular mutation in the HIV envelope gene. The study ...
... pilgrim died of respiratory problems while on a tour ... woman too succumbed// to high-altitude illness while pursuing the ... pilgrim sites in Asia is fast turning into a ... Devi Shriram Bhoyar, a 38-year-old god woman from Maharashtra, ...
... Sandip Datta and Joshua Fierer of the University of ... gamma radiation// killed bacteria are very effective in inducing ... ,The U.S. National Institute of Allergy and Infectious ... said that these bacterial cultures could be used as ...
Cached Medicine News:Health News:FDA Approves New Test For Screening Infection In Babies 2Health News:FDA Approves New Test For Screening Infection In Babies 3Health News:Diagnosing Schizophrenia 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 3Health News:Mutation in the Envelope Gene May Be the Reason for the Development of HIV Linked Cognitive Decline 2Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... a press release on July 28, 2015, "Surviving ... Safety Launches Fundraising for Patient Safety." ... last sentence should read: "PPAHS is ... of Patients on Opioids. For more information on the ...
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... Oct. 26 Palomar Pomerado Health (PPH), a Magnet® ... has been selected by San Diego-based CareFusion, a global ... latest Pyxis technologies that focus on improving the safety ... partner in innovation with CareFusion, PPH physicians, nurses, pharmacists, ...
... Oct. 26 Nautilus Neurosciences, Inc., a neurology-focused specialty ... pivotal safety and efficacy studies of CAMBIA™ (diclofenac potassium ... World Congress on Controversies in Neurology Conference (CONy) in ... presented in a poster (#23) entitled, "Rapid and Sustained ...
Cached Medicine Technology:CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies 2CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies 3New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 2New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 3New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 4